COVID-19 and immunomodulator/immunosuppressant use in dermatology
Top Cited Papers
Open Access
- 26 March 2020
- journal article
- letter
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 82 (5), e173-e175
- https://doi.org/10.1016/j.jaad.2020.03.046
Abstract
No abstract availableKeywords
Funding Information
- Sanofi Genzyme
- AbbVie
- Regeneron Pharmaceuticals
This publication has 4 references indexed in Scilit:
- Should biologics for psoriasis be interrupted in the era of COVID-19?Journal of the American Academy of Dermatology, 2020
- Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemicAsian Pacific Journal of Allergy and Immunology, 2020
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreakJournal of Autoimmunity, 2020
- Coronavirus infections and immune responsesJournal of Medical Virology, 2020